2022
DOI: 10.1161/jaha.122.025628
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Edge‐to‐Edge Repair for Systemic Atrioventricular Valve Regurgitation in Patients With Congenital Heart Disease: The First Descriptive Cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 5 publications
0
7
0
Order By: Relevance
“…To date, there only rare case reports available describing the use of TEER intervention to improve AVVR in adult congenital heart patients. 13 , 14 To our knowledge, this is the first successful published example of TEER through an extracardiac Fontan baffle puncture to successfully treat AV valve regurgitation in an adult.…”
Section: Discussionmentioning
confidence: 93%
“…To date, there only rare case reports available describing the use of TEER intervention to improve AVVR in adult congenital heart patients. 13 , 14 To our knowledge, this is the first successful published example of TEER through an extracardiac Fontan baffle puncture to successfully treat AV valve regurgitation in an adult.…”
Section: Discussionmentioning
confidence: 93%
“…There is increasing evidence supporting TEER as an AV therapy in high-risk adult patients, and there are further trials investigating expanding use in moderate-risk patients. 1,[21][22][23][24] While there have been case reports and a series of applications of TEER in CHD, [8][9][10][11][12]25 to date there has not been an organized effort to expand the use of TEER technologies to the heterogenous, anatomically complex CHD population due to the inherent challenges associated with widely varying anatomies, mechanisms of valve dysfunction, and delivery systems designed for "structurally normal" hearts.…”
Section: Discussionmentioning
confidence: 99%
“…As such, the development and application of an effective and minimally invasive therapy for AVVR would address a critical unmet need 6,7 . However, application of TEER in CHD, and in particular palliated single ventricle patients, is novel with limited description of outcomes 8−12 …”
Section: Introductionmentioning
confidence: 99%
“…Transcatheter edge-to-edge valve repair with clip implantation has been used to treat mitral and TR in congenitally normal hearts. Case reports and series implanting clips in the SAVV tricuspid position in d-TGA and cc-TGA have also reported good clinical and echocardiographic improvement ( 115 ). Albeit more extensive studies with longer follow-ups are needed for validation, this percutaneous-based clip implantation may be suitable for sRV patients at high surgical risk ( 116 ).…”
Section: Management Of the Failing Systemic Right Ventriclementioning
confidence: 99%